MAUDE Adverse Event Report: TORAX MEDICAL, INC. LXC12; ANTI-REFLUX IMPLANT

Model Number LXC-[12]

Device Problems Migration or Expulsion of Device (1395); Patient Device Interaction Problem (4001)

Patient Problems Erosion (1750); Dysphagia/ Odynophagia (1815); No Code Available (3191)

Event Date 07/08/2020

Event Type  Injury  

Manufacturer Narrative

(b)(4).As the device was not returned, an analysis investigation could not be performed.A conclusion could not be reached as to what may have caused, or contributed to the event.Additional information was requested, and the following was received: what was the date of implant? (b)(6) 2015.What is the lot number of the device? 6726.What were the first clinical symptoms that provided evidence of an erosion, and when did they first occur? (b)(6) 2020; increased dysphagia.Has the patient had any dilations, egd, or other procedure between the linx implant and discovery of the erosion? yes.If yes, please describe and include the dates of the procedures.Egd (b)(6) 2017, linx in good position, no esophagitis; bravo ph testing normal; biopsies unremarkable.Are pictures or videos available? yes.Where were the eroded beads positioned? posterior.Was the patient stented? no.What is the current condition of the patient? still having significant dysphagia with almost daily impactions, usually pass.When using the linx sizing device what technique was used to determine the size? linx calibration device; two measurements taken; chosen size was 2 beads above the pop-off.Did the patient have an autoimmune disease? no.Is the patient currently taking steroids / immunization drugs? no.Did the patient have any pre-existing dysphagia or other conditions (other than gerd)? no, normal preoperative esophageal manometry.How severe was the dysphagia/odynophagia before intervention? severe with substantial weight loss.Were there any intra-operative complications during implant? none.Was there any hiatal or crural repair done at the same time as the implant? no.Were there any other contributing factors that led to the removal of the device other than the reported dysphagia? bead erosion into esophageal lumen.What was the reason for removal of the linx device? bead erosion into esophageal lumen.Was the device found in the correct position/geometry at the time of removal? yes aside from erosion; still encircling ge junction.Device has been discarded.Per photographic evaluation: as per medical safety officer, who reviewed some upper gi endoscopy images associated with this complaint.The images showed erosion of the linx device into the lumen of the lower esophagus.Three to four linx beads were visible dependent on the view.The complete 12 bead linx device was successfully removed endoscopically.The mechanism/cause of failure cannot be determined from the provided images.The dhr for lot 6726 was reviewed.No ncs, defects, or reworks related to the product complaint were found.

Event Description

It was reported that during an edg on (b)(6) 2020, it was found that 3 beads of the linx device were partially eroded.The patient returned on (b)(6) 2020 for explant.Explant was successful.

Manufacturer Narrative

(b)(4).Date sent: 10/12/2020.

• Brand Name: LXC12
• Type of Device: ANTI-REFLUX IMPLANT
• Manufacturer (Section D): TORAX MEDICAL, INC.; 4188 lexington avenue north; shoreview MN
• MDR Report Key: 10662542
• MDR Text Key: 215263666
• Report Number: 3008766073-2020-00160
• Device Sequence Number: 1
• Product Code: LEI
• UDI-Device Identifier: 00855106005134
• UDI-Public: 00855106005134
• Combination Product (y/n): N
• PMA/PMN Number: P100049
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: study
• Type of Report: Initial,Followup
• Report Date: 09/24/2020

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Device Operator: Health Professional
• Device Expiration Date: 09/10/2018
• Device Model Number: LXC-[12]
• Device Catalogue Number: LXC12
• Device Lot Number: 6726
• Was Device Available for Evaluation?: No
• Initial Date Manufacturer Received: 09/24/2020
• Initial Date FDA Received: 10/12/2020
• Supplement Dates Manufacturer Received: 09/24/2020
• Supplement Dates FDA Received: 10/12/2020
• Patient Sequence Number: 1
• Patient Outcome(s): Required Intervention
• Patient Age: 61 YR